CD274 and nonpapillary renal cell carcinoma: To delve into the potential correlation between the heterogeneity of TLS and the response to immunotherapy, our study engaged 230 patients diagnosed with advanced ccRCC who underwent postoperative adjuvant therapy involving anti‐PD‐1/PD‐L1 combined with TKIs therapy from the FU‐ICIs cohort.